Company intelligence / Profile preview
Ardanza Biopharma
Zug, Zug, Switzerlandardanzabiopharma.com ↗
- Ownership
- Private
- Employees
- ~8
- Development stage
- Other
01
Overview
Ardanza Biopharma is a Swiss clinical-stage ready biopharmaceutical company focused on developing innovative, cost-effective, and improved therapies for diseases with high unmet medical needs. The company's lead program, ARD-100, is a novel oral monomethyl fumarate (MMF) prodrug combined with eicosapentaenoic acid (EPA) designed to treat relapsing-remitting multiple sclerosis (RRMS) with enhanced tolerability and simplified daily dosing. Ardanza Biopharma aims to expand its pipeline into other autoimmune diseases and oncology by optimizing established standard-of-care small molecule therapies. Headquartered in Zug, Switzerland, the company is led by an experienced team of pharmaceutical executives and scientific advisors.
- Therapeutic areas
- NeurologyOncologyImmunology
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Ardanza Biopharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ardanza Biopharma.